Matches in Wikidata for { <http://www.wikidata.org/entity/Q80336815> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q80336815 description "artículu científicu espublizáu en mayu de 2007" @default.
- Q80336815 description "im Mai 2007 veröffentlichter wissenschaftlicher Artikel" @default.
- Q80336815 description "scientific article published on 01 May 2007" @default.
- Q80336815 description "wetenschappelijk artikel" @default.
- Q80336815 description "наукова стаття, опублікована в травні 2007" @default.
- Q80336815 name "Key amprenavir resistance mutations counteract dramatic efficacy of darunavir in highly experienced patients" @default.
- Q80336815 name "Key amprenavir resistance mutations counteract dramatic efficacy of darunavir in highly experienced patients" @default.
- Q80336815 type Item @default.
- Q80336815 label "Key amprenavir resistance mutations counteract dramatic efficacy of darunavir in highly experienced patients" @default.
- Q80336815 label "Key amprenavir resistance mutations counteract dramatic efficacy of darunavir in highly experienced patients" @default.
- Q80336815 prefLabel "Key amprenavir resistance mutations counteract dramatic efficacy of darunavir in highly experienced patients" @default.
- Q80336815 prefLabel "Key amprenavir resistance mutations counteract dramatic efficacy of darunavir in highly experienced patients" @default.
- Q80336815 P1433 Q80336815-FB4C653C-6E11-44EE-B367-BF8464739334 @default.
- Q80336815 P1476 Q80336815-E1D3F4B7-89D8-4950-888E-BE8A0676C0CE @default.
- Q80336815 P2093 Q80336815-0094B6AB-4F32-462C-995A-BB15069F6DDD @default.
- Q80336815 P2093 Q80336815-20009DD1-5EC1-439C-831B-0CD40CEB67B3 @default.
- Q80336815 P2093 Q80336815-4378DCDD-2E95-440A-962E-65B286F8AA20 @default.
- Q80336815 P2093 Q80336815-675F7E36-C589-4B2F-86D2-20CDDC7D1401 @default.
- Q80336815 P2093 Q80336815-9416C2D9-02DE-45D7-9461-1A8E40533933 @default.
- Q80336815 P2093 Q80336815-AEF7DD03-01A3-4261-9224-437FB7959B82 @default.
- Q80336815 P304 Q80336815-3B658106-45E4-4863-8CDA-2F0395ACCC73 @default.
- Q80336815 P31 Q80336815-060BC05A-EBE5-424C-8750-3B9821212CD8 @default.
- Q80336815 P356 Q80336815-4367E014-2DF9-4AD7-A791-44A444F845EF @default.
- Q80336815 P433 Q80336815-56A7228F-CEE8-432E-9778-0FD5ADD51CEE @default.
- Q80336815 P478 Q80336815-876D0184-5D68-4F5F-BBF0-69C341202A7D @default.
- Q80336815 P50 Q80336815-6D584AE3-CCDF-4615-8769-938A5A4D5419 @default.
- Q80336815 P577 Q80336815-45B94968-ECB7-4975-BB57-8079695D8D00 @default.
- Q80336815 P698 Q80336815-66C052A1-5190-44B2-BEDA-3545AFFD317A @default.
- Q80336815 P921 Q80336815-A0B3024A-057D-4945-86A9-96E5D2FEF420 @default.
- Q80336815 P356 QAD.0B013E32810FD744 @default.
- Q80336815 P698 17502734 @default.
- Q80336815 P1433 Q4651863 @default.
- Q80336815 P1476 "Key amprenavir resistance mutations counteract dramatic efficacy of darunavir in highly experienced patients" @default.
- Q80336815 P2093 "Dominique Mathez" @default.
- Q80336815 P2093 "Gilles Peytavin" @default.
- Q80336815 P2093 "Huguette Berthé" @default.
- Q80336815 P2093 "Kivan Long" @default.
- Q80336815 P2093 "Pierre de Truchis" @default.
- Q80336815 P2093 "Tatiana Galperine" @default.
- Q80336815 P304 "1210-1213" @default.
- Q80336815 P31 Q13442814 @default.
- Q80336815 P356 "10.1097/QAD.0B013E32810FD744" @default.
- Q80336815 P433 "9" @default.
- Q80336815 P478 "21" @default.
- Q80336815 P50 Q111077180 @default.
- Q80336815 P577 "2007-05-01T00:00:00Z" @default.
- Q80336815 P698 "17502734" @default.
- Q80336815 P921 Q3765251 @default.